This statistic shows the median merger and acquisition ( M & A ) value to revenue multiple for generic pharmaceutical M & A deals worldwide from 2011 to 2015 . In 2015 , the median M & A value to revenue multiple was 5.1 , almost double what it was in 2011 .
